| Authors: |
Hassan R; Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Thomas A; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Nemunaitis JJ; Division of Hematology and Oncology, University of Toledo College of Medicine, Toledo, Ohio., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota., Bennouna J; Department of Pneumology, Thoracic Oncology Unit, University Hospital of Nantes, Nantes, France., Chen FL; Novant Health Oncology Specialists, Winston-Salem, North Carolina., Delord JP; Institut Universitaire du Cancer-Oncopole, Toulouse, France., Dowlati A; Division of Hematology and Oncology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio., Kochuparambil ST; Virginia Piper Cancer Institute, Minneapolis, Minnesota., Taylor MH; Knight Cancer Institute, Oregon Health & Science University, Portland., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Verschraegen C; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus., Grote HJ; Merck KGaA, Darmstadt, Germany., von Heydebreck A; Merck KGaA, Darmstadt, Germany., Chin K; EMD Serono, Billerica, Massachusetts., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. |
